1 Departments of Pediatrics and Medicine, College of Physicians and Surgeons, Columbia University, New York
An 18-month-old infant presented with ventricular tachycardia. The arrhythmia was controlled only with procaineamide in a dose of 3,600 mg/day. A plasma procaineamide level was 9 µg/ml which is within the therapeutic range previously described for adults. Poor absorption, increased tolerance of the agent, and a large volume of distribution relative to body weight may account for the high dosage required. No etiology for the arrhythmia was found and the child made an uneventful recovery. The pharmacological effects of procaineamide on cardiac electrophysiology are discussed.
This article has been cited by other articles:
![]() |
The International Liaison Committee on Resuscitati The International Liaison Committee on Resuscitation (ILCOR) Consensus on Science With Treatment Recommendations for Pediatric and Neonatal Patients: Pediatric Basic and Advanced Life Support Pediatrics, May 1, 2006; 117(5): e955 - e977. [Abstract] [Full Text] [PDF] |
||||
![]() |
Part 6: Pediatric Basic and Advanced Life Support Circulation, November 29, 2005; 112(22_suppl): III-73 - III-90. [Full Text] [PDF] |
||||
![]() |
T. Ayabe and P. Chiemmongkoltip Persistent Ventricular Tachycardia in a Newborn Infant: Symptomatic Control for Over 18 Months with Propranolol Clinical Pediatrics, January 1, 1978; 17(1): 93 - 95. [PDF] |
||||